Royalty Pharma plc
RPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802768
In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 5 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Royalty Pharma plc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 458
- +15 vs. Q1 2025
- Shares held
- 342.7M
- +32.2M (+10.4%) vs. Q1 2025
- Total value
- $12.4B
- +$2.69B (+27.8%) vs. Q1 2025
- New holders
- 77
- 173 more added
- Sold out
- 62
- 156 more reduced
4 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 650 | $20.6B |
| Q1 2026 | 594 | $17.0B |
| Q4 2025 | 542 | $13.8B |
| Q3 2025 | 490 | $11.6B |
| Q2 2025 | 458 | $12.4B |
| Q1 2025 | 447 | $9.67B |
| Q4 2024 | 417 | $8.21B |
| Q3 2024 | 396 | $8.85B |
| Q2 2024 | 380 | $8.36B |
| Q1 2024 | 381 | $9.49B |
| Q4 2023 | 364 | $8.74B |
| Q3 2023 | 315 | $8.17B |
| Q2 2023 | 327 | $9.33B |
| Q1 2023 | 338 | $10.9B |
| Q4 2022 | 338 | $11.8B |
| Q3 2022 | 320 | $12.0B |
| Q2 2022 | 286 | $12.3B |
| Q1 2022 | 280 | $10.5B |
| Q4 2021 | 267 | $10.7B |
| Q3 2021 | 234 | $9.59B |
| Q2 2021 | 238 | $10.3B |
| Q1 2021 | 216 | $10.7B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Royalty Pharma plc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −5,085−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −2,917−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −2,595−100.0% | Sold out |
| Friedenthal Financial | 0 | $0 | 0.00% | −2,479−100.0% | Sold out |
| Westpac Banking Corp | 0 | $0 | 0.00% | −2,060−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,475−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −1,216−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −1,195−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −1,163−100.0% | Sold out |
| Louisbourg Investments Inc. | 0 | $0 | 0.00% | −905−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −715−100.0% | Sold out |
| ZynergyRetirementPlanningLLC | 0 | $0 | 0.00% | −748−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −474−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −428−100.0% | Sold out |
| Saudi Central Bank | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| ROSS\JOHNSON & Associates LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Quent Capital, LLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| MPWM Advisory Solutions, LLC | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Credit Agricole S A | – | – | – | – | Not filed |
| Rakuten Investment Management, Inc. | – | – | – | – | Not filed |
| Orion Portfolio Solutions, LLC | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |